Document Detail


Clinical and electrophysiologic evolution of the Wolff-Parkinson-White syndrome in children: impact on approaches to management.
MedLine Citation:
PMID:  10950334     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is less certainty about the recommendations for radio-frequency ablation as a therapeutic option for Wolff-Parkinson-White syndrome in children as opposed to adults because of the different natural history and the age-related risks of ablation. To help decision-making, we evaluated the long term clinical evolution and electrophysiologic characteristics of pre-excitation in our series of children and young adults. We reviewed the clinical course of 109 patients below the age of 18 years who had been followed up over a period of 9+4 years, with a range from one to 27 years. This corresponded to 986 patient-years. We examined also the electrophysiologic data from 98 of those patients who underwent a transesophageal study. At the discovery of pre-excitation, 59% of patients were asymptomatic, while 29% developed supraventricular tachycardia during follow-up. The peak incidence of the onset of supraventricular tachycardia occurred during infancy. These patients had the highest incidence of subsequent spontaneous disappearance of the tachycardia (53%), such a favourable evolution being encountered in only 12% of patients in whom the abnormal rhythm first appeared after 12 years of age. Chronic medical treatment was required in 47% of patients, and proved completely effective in 45% of cases. The potential to induce atrial fibrillation, and the incidence pre-excitation considered to be high risk, with the shortest pre-excited RR interval equal to or less than 220 msec, was lowest in the group of patients aged less than 6 years of age, and highest in those older than 12 years of age (p <0.001). Pathways producing arrhythmia with high risk were more common in symptomatic (29%) than in asymptomatic patients (7%) (p<0.001). No mortality occurred. On the basis of our findings, we suggest that ablation should be avoided before the age of 5 or 6 years. Thereafter, the procedure should become the first line of treatment for symptomatic patients older than 12 years of age.
Authors:
G Vignati; E Balla; L Mauri; M Lunati; A Figini
Related Documents :
20047924 - Prospective evaluation of non-pharmacological treatment in vasovagal syncope.
18242544 - Long-term outcome of twin atrioventricular node and supraventricular tachycardia in pat...
14560324 - The usefulness of tilt testing with an intravenous beta-blocker in assessing the effica...
10750134 - Defibrillators in nonischemic cardiomyopathy treatment evaluation.
23290984 - Photoreceptor outer segment length: a prognostic factor for idiopathic epiretinal membr...
3599234 - Management of renal artery injuries from external trauma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cardiology in the young     Volume:  10     ISSN:  1047-9511     ISO Abbreviation:  Cardiol Young     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-11-29     Completed Date:  2000-12-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9200019     Medline TA:  Cardiol Young     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  367-75     Citation Subset:  IM    
Affiliation:
Department of Cardiology De'Gasperis, Niguarda Hospital, Milan, Italy. famvi@iol.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Age Factors
Catheter Ablation / adverse effects*
Child
Child, Preschool
Decision Making
Disease Progression
Echocardiography, Transesophageal
Female
Follow-Up Studies
Humans
Incidence
Infant
Infant, Newborn
Male
Patient Selection*
Risk Factors
Tachycardia, Supraventricular / etiology*
Treatment Outcome
Wolff-Parkinson-White Syndrome / diagnosis*,  therapy*
Comments/Corrections
Comment In:
Cardiol Young. 2000 Oct;10(4):303-6   [PMID:  10950327 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Outcomes for children with cardiomyopathy awaiting transplantation.
Next Document:  Radiofrequency catheter ablation for the treatment of supraventricular tachycardias in children and ...